Skip to main content
Dec. 3rd 2018: Ocular Therapeutix
™
Announces FDA Approval of DEXTENZA
®
About
Company
Hydrogel Technology
History
Leadership
Clinical Trials
Contact Us
Pipeline
OTX-TP (travoprost insert)
OTX-TIC (travoprost implant)
OTX-TKI (tyrosine kinase inhibitor implant)
OTX-IVT (anti-VEGF antibody implant)
Products
DEXTENZA
®
ReSure® Sealant
Investors
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
Stock Information
Analyst Coverage
Historical Price Lookup
Investment Calculator
Press Releases
Calendar of Events
Corporate Presentation
Investor FAQs
Information Request
Careers
Core Values + Benefits
Open Positions
Search
Past Events
Upcoming Events
| Past Events
Archived Events
There are no past events to display.
Archived Industry Events
There are no past events to display.
Print
E-mail
RSS
X
Share on:
E-mail
Facebook
Twitter
LinkedIn
Google+
Google
What's This?
Share this page through your favorite social channel or email this page to a colleague.
Share
Alerts
Contact
Tear Sheet